Variation in the histopathological features of patients with ascending aortic aneurysms: A study of 111 surgically excised cases

Journal of Clinical Pathology

Volumn 61, Issue 4, 2008, Pages 519-523

  Collins, M J ^a   Dev, V ^a   Strauss, B H ^b,c   Fedak, P W M ^a   Butany, Jagdish ^a,c  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN;

ADOLESCENT; ADULT; AGED; AORTA ANEURYSM; AORTA VALVE DISEASE; ARTICLE; ASCENDING AORTA; BICUSPID AORTIC VALVE; CELL LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; PROTEIN DEPLETION; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; TRICUSPID AORTIC VALVE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM; AORTIC VALVE; ELASTIC TISSUE; ELASTIN; FEMALE; HUMANS; MALE; MARFAN SYNDROME; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; SEX FACTORS; TUNICA INTIMA;

EID: 42049117121     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.046250     Document Type: Article

References (19)

1. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005;365:1577-89.
2. Gillum RF. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol 1995;48:1289-98.
3. Lederle FA, Johnson GR, Wilson SE, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000;160:1425-30.
4. Thompson RW. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol 1996;11:504-18.
5. Hasham SN, Guo DC, Milewicz DM. Genetic basis of thoracic aortic aneurysms and dissections. Curr Opin Cardiol 2002;17:677-83.
6. Collins MJ, Butany J, Fedak PWM, et al. Ascending aortic aneurysm pathogenesis from a molecular perspective. Cardiovacular Pathology. In press.
7. Annabi B, Shedid D, Ghosn P, et al. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg 2002;35:539-46.
8. Kadoglou NP, Liapis CD. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 2004;20:419-32.
9. LeMaire SA, Wang X, Wilks JA, et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res 2005;123:40-8.
10. Matthias Bechtel JF, Noack F, Sayk F, et al. Histopathological grading of ascending aortic aneurysm: comparison of patients with bicuspid versus tricuspid aortic valve. J Heart Valve Dis 2003;12:54-61.
11. Ikonomidis JS, Gibson WC, Butler JE, et al. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms. Circulation 2004;110:11268-273.
12. Absi TS, Sundt TM 3rd, Tung WS, et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 2003;126:344-357.
13. Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318-26.
14. Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-9.
15. Ailawadi G, Knipp BS, Lu G, et al. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg 2003;37:1059-66.
16. Borger MA, Preston M, Ivanov J, et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg 2004;128:677-83.
17. Fedak PW, David TE, Borger M, et al. Bicuspid aortic valve disease: recent insights in pathophysiology and treatment. Expert Rev Cardiovasc Ther 2005;3:295-308.
18. Fedak PW, de Sa MP, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 2003;126:797-806.
19. Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 1997;30:1809-12.